Griseofulvin (Qualitest Pharmaceuticals)


Welcome to the PulseAid listing for the Griseofulvin drug offered from Qualitest Pharmaceuticals. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Qualitest Pharmaceuticals
NON-PROPRIETARY NAME: Griseofulvin
SUBSTANCE NAME: GRISEOFULVIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-10-08
END MARKETING DATE: 2018-02-28


Griseofulvin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGriseofulvin from Qualitest Pharmaceuticals
LABELER NAME: Qualitest Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 125(mg/5mL)
START MARKETING DATE: 2010-10-08
END MARKETING DATE: 2018-02-28
PRODUCT ID: 0603-9171_edba0d01-d72e-48de-9528-9ddf9fd1a838
PRODUCT NDC: 0603-9171
APPLICATION NUMBER: ANDA065438

Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Griseofulvin
Cipla USA Inc.grisofulvin
CorePharma, LLCUltramicrosize Griseofulvin
Oceanside PharmaceuticalsGriseofulvin
Pedinol Pharmacal, Inc.Gris-PEG
Physicians Total Care, Inc.Griseofulvin
Qualitest PharmaceuticalsGriseofulvin
Rebel Distributors CorpGriseofulviin (microsize)
RiconPharma LLC.Ultramicrosize Griseofulvin
Rising Pharmaceuticals Inc.Griseofulvin
Rising Pharmaceuticals, IncGriseofulvin
Sandoz IncGriseofulvin
State of Florida DOH Central PharmacyGris-PEG